WallStreetZenWallStreetZen

NASDAQ: DRIO
Dariohealth Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DRIO past revenue growth

How has DRIO's revenue growth performed historically?
Company
6.75%
Industry
5.94%
Market
14.01%
DRIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DRIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DRIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DRIO earnings and revenue history

Current Revenue
$26.7M
Current Earnings
-$60.3M
Current Profit Margin
-226.1%

DRIO Return on Equity

Current Company
-70.8%
Current Industry
-180.9%
Current Market
30.8%
DRIO's Return on Equity (-70.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DRIO announces earnings.

DRIO Return on Assets

Current Company
-49.1%
Current Industry
5.6%
DRIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DRIO Return on Capital Employed

Current Company
-65.38%
Current Industry
9.8%
DRIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DRIO vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DRIO$26.66M-$54.20M-$60.29M+35.12%N/A
BDSX$40.72M-$53.04M-$68.56M-23.36%N/A
ANIX$0.00-$12.05M-$12.09M-100.00%N/A
MDXHN/AN/AN/AN/AN/A
ENZ$81.12M-$32.58M-$35.24M-5.13%N/A
View Top Diagnostic & Research Stocks

Dariohealth Earnings & Revenue FAQ

What were DRIO's earnings last quarter?

On Invalid Date, Dariohealth (NASDAQ: DRIO) reported Q1 2023 earnings per share (EPS) of -$0.45, up 39.19% year over year. Total Dariohealth earnings for the quarter were -$12.83 million. In the same quarter last year, Dariohealth's earnings per share (EPS) was -$0.74.

If you're new to stock investing, here's how to buy Dariohealth stock.

What was DRIO's earnings growth in the past year?

As of Q2 2023, Dariohealth's earnings has grown year over year. Dariohealth's earnings in the past year totalled -$60.29 million.

What was DRIO's revenue last quarter?

On Invalid Date, Dariohealth (NASDAQ: DRIO) reported Q1 2023 revenue of $7.07 million up 12.32% year over year. In the same quarter last year, Dariohealth's revenue was $8.06 million.

What was DRIO's revenue growth in the past year?

As of Q2 2023, Dariohealth's revenue has grown 6.75% year over year. This is 0.81 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 5.94%. Dariohealth's revenue in the past year totalled $26.66 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.